Jacobs Levy Equity Management’s GoodRx Holdings GDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding GDRX
FPM
VCM
SLG
VPM
PTC
PGCM
Jacobs Levy Equity Management's GDRX Position: Q1 2026 in Review
Jacobs Levy Equity Management sold out of GoodRx Holdings (GDRX) in Q1 2026, closing a stake of 336,972 shares — an estimated $913K sold.
Jacobs Levy Equity Management first reported a position in GDRX in Q3 2022 and held it in 13 quarters. The position peaked at $6.75M in Q3 2022. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.
- Jacobs Levy Equity Management reported no remaining GoodRx Holdings position as of Q1 2026 after selling out during the quarter.
- Jacobs Levy Equity Management sold 336,972 GoodRx Holdings shares in Q1 2026, an estimated $913K.
- Jacobs Levy Equity Management first reported a position in GoodRx Holdings in Q3 2022 and held it in 13 quarters.
- Jacobs Levy Equity Management's GoodRx Holdings position peaked at $6.75M in Q3 2022.
- 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.